 "Sun Pharma")
Drug major Sun Pharmaceutical Industries on Tuesday reported a 12.92 per cent rise in its consolidated net profit to Rs 2,047.01 crore for the quarter ended on September 30, 2021.
The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
Consolidated revenue from operations stood at Rs 9,625.93 crore for the quarter under consideration against Rs Rs 8,553.13 crore for the same period a year ago, it added.
Shares of Sun Pharmaceutical Industries were trading at Rs 816.05 per scrip on BSE, up 0.53 per cent from its previous close.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
